It’s common practice to start with less intensive DMTs when you’re newly diagnosed. But MS experts are now debating if we should start treating people with intensive DMTs as soon as they get diagnosed.
Every day researchers dedicate their work to investigating MS. But many of them also have a personal connection to MS. Dr Rachael Hunter and Dr Charlotte Spicer told us about what motivates them.
Dr Alison Thomson is a senior lecturer at Queen Mary University. She wants to design better, more inclusive MS services that involve people with lived experience of MS in all stages research.
Associate Professor Rod Middleton leads the UK MS Register. We spoke to Rod to find out what led him there, and what the future of the Register might have in store.